Cloning, expression and characterization of the overall sequence of phosphodiesterase 8B
US6465465B1
Process for the treatment of erectile dysfunction and product therefor
DE10053275A1
New 7-aza-indole-3-carboxamides or glyoxylamides, useful e.g. for treating rheumatoid arthritis, osteoporosis, sepsis, asthma or multiple sclerosis are phosphodiesterase-4 and tumor necrosis factor-alpha inhibitors
DE10042093A1
Anticonvulsant 6,7-dihydro-pyrrolo [3,4-d] pyridin-5-ones and process for their preparation
DE10042092A1
Anticonvulsant 2,5-dihydro-pyrazolo (3,4-d) pyrimidin-4-ones and process for their preparation
DE10012373A1
Treating erectile dysfunction using new or known imidazo(1,5-a)pyrido(3,2-e)pyrazinone derivatives, as cGMP-selective phosphodiesterase V inhibitors free of cardiovascular side-effects
DE10010509A1
Oral pharmaceutical formulations with controllable release characteristics, e.g. rapid or delayed release, contain sucrose fatty acid ester as drug release controlling agent
SK10322001A3
Process for the preparation of imidazo[1,5-a]-pyrido[3,2-e] pyrazinones, pharmaceutical compositions comprising said compounds and method for producing pharmaceutical compositions
DE19961302A1
Treatment of erectile dysfunction using new or known imidazo(1,5-a)pyrido(3,2-e)pyrazinones as phosphodiesterase inhibitors, some of which are also useful for treating cardiovascular disorders
DE19944332A1
Anticonvulsant and anxiolytic 4-amino-1-aryl-1,5-dihydro-pyrrol-2-ones and process for their preparation
US6472165B1
Modulatory binding site in potassium channels for screening and finding new active ingredients
CZ2001450A3
Novel 4-amino-1-arylpyridin-2-ones exhibiting anticonvulsive activity and process of their preparation
DE19924872A1
Anticonvulsant pyrazolo [3,4-d] [1,2,3] triazines and process for their preparation
IL138847D0
New hydroxyindoles, their use as phosphodiesterase 4 inhibitors and method for producing same
DE19917504A1
New hydroxy-indole derivatives, useful in treatment of degenerative joint disease, viral and parasitic infections, bronchial, dermatological, neurodegenerative and prostate disorders, etc.
DE19917505A1
Treating cytokine-mediated diseases, e.g. asthma, allergy, eczema, rheumatoid arthritis or transplant rejection, using new or known maduraphthalazine derivatives
CZ20004152A3
Novel 1,5 and 3-0-substituted 1H-indazoles exhibiting anti-asthmatic, antiallergic, antiphlogistic, immunomodulating and neuroprotective activity, process of their preparation and their use as medicaments
CZ20004168A3
Novel 1,2,5-trisubstituted 1,2-dihydroindazol-3-ones exhibiting anti-asthmatic, antiallergic, antiphlogistic, immunomodulating and neuroprotective activity, process of their preparation and their use as medicaments
DE19902082A1
New and known imidazo(1,5-a)pyrido(3,2-e)pyrazinone derivatives, useful as phosphodiesterase 5 inhibitors for treating erectile dysfunction
